These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 6214134

  • 1. The effect of cyproterone acetate on pituitary-ovarian function and clinical symptoms in hirsute women.
    Lunell NO, Zador G, Carlström K, Eneroth P, Patek E, Wager J.
    Acta Endocrinol (Copenh); 1982 May; 100(1):91-7. PubMed ID: 6214134
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Impaired pregnenolone secretion after combined cyproterone acetate and ethynyl estradiol therapy in hirsute patients.
    Inaudi P, D'Ambrogio G, Massafra C, Facchini V, Genazzani AR.
    Gynecol Obstet Invest; 1982 May; 14(2):106-20. PubMed ID: 6288518
    [Abstract] [Full Text] [Related]

  • 5. Treatment of idiopathic hirsute women with two combinations of cyproterone acetate.
    Salva P, Morer F, Ordoñez J, Rodriguez J.
    Int J Clin Pharmacol Res; 1983 May; 3(2):129-35. PubMed ID: 6237068
    [Abstract] [Full Text] [Related]

  • 6. Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol.
    Kuttenn F, Rigaud C, Wright F, Mauvais-Jarvis P.
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1107-11. PubMed ID: 6448264
    [Abstract] [Full Text] [Related]

  • 7. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives.
    Porcile A, Gallardo E.
    Fertil Steril; 1991 May; 55(5):877-81. PubMed ID: 1827074
    [Abstract] [Full Text] [Related]

  • 8. Androgen levels during cyproterone acetate and ethinyl oestradiol treatment of hirsutism.
    Rubens R.
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):313-25. PubMed ID: 6233049
    [Abstract] [Full Text] [Related]

  • 9. The treatment of essential hirsutism in women with cyproterone acetate and ethinyl estradiol. Clinical and endocrine effects in 10 cases.
    Frey H, Aakvaag A.
    Acta Obstet Gynecol Scand; 1981 Mar; 60(3):295-300. PubMed ID: 6455899
    [Abstract] [Full Text] [Related]

  • 10. The evaluation of the role of androgens in hirsutism and the use of a new anti-androgen "cyproterone acetate" for therapy.
    Ismail AA, Davidson DW, Souka AR, Barnes EW, Irvine WJ, Kilimnik H, Vanderbeeken Y.
    J Clin Endocrinol Metab; 1974 Jul; 39(1):81-95. PubMed ID: 4835125
    [No Abstract] [Full Text] [Related]

  • 11. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
    Spona J, Huber J, Schmidt JB.
    Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
    [Abstract] [Full Text] [Related]

  • 12. Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on clinical signs of androgenization, hormone profile and ovarian size in patients with polycystic ovary syndrome.
    Prelević GM, Würzburger MI, Balint-Perić L, Puzigaća Z.
    Gynecol Endocrinol; 1989 Dec; 3(4):269-80. PubMed ID: 2516704
    [Abstract] [Full Text] [Related]

  • 13. The influence of long-term treatment with cyproterone acetate or a cyproterone acetate-ethinyl oestradiol combination on androgen levels in blood of hirsute women.
    Frölich M, Vader HL, Walma ST, De Rooy HA.
    J Steroid Biochem; 1980 Jan; 12():499-501. PubMed ID: 6448324
    [No Abstract] [Full Text] [Related]

  • 14. Effect of cyproterone acetate-ethinyl oestradiol treatment on adrenal function in hirsute women.
    Chapman MG, Jeffcoate SL, Dewhurst CJ.
    Clin Endocrinol (Oxf); 1982 Dec; 17(6):577-82. PubMed ID: 6299625
    [Abstract] [Full Text] [Related]

  • 15. [The response to gonadotropin-releasing hormone in hirsutism after treatment with cyproterone acetate].
    Kocijancic A, Pfeifer M, Prezelj J, Meden-Vrtovec H, Vrhovec I.
    Jugosl Ginekol Opstet; 1982 Dec; 22(1-2):16-9. PubMed ID: 6215543
    [Abstract] [Full Text] [Related]

  • 16. Cyproterone acetate: a study involving two volunteers with idiopathic hirsutism.
    Barnes EW, Irvine WJ, Hunter WM, Ismail AA.
    Clin Endocrinol (Oxf); 1975 Jan; 4(1):65-73. PubMed ID: 1122656
    [Abstract] [Full Text] [Related]

  • 17. Contraceptive and therapeutic effectiveness of two low-dose ethinylestradiol and cyproterone acetate regimens in the treatment of hirsute patients.
    Venturoli S, Ravaioli B, Bagnoli A, Colombo FM, Macrelli S, Iadarola I, Vianello F, Mancini F, Flamigni C.
    Eur J Contracept Reprod Health Care; 1998 Mar; 3(1):29-33. PubMed ID: 9678070
    [Abstract] [Full Text] [Related]

  • 18. Activation of PRL secretion by combined treatment with cyproterone acetate and ethinylestradiol.
    Valenti G, Vescovi PP, Gerra G, Rastelli G, Butturini U.
    J Endocrinol Invest; 1985 Jun; 8(3):269-72. PubMed ID: 3161934
    [Abstract] [Full Text] [Related]

  • 19. Cyproterone acetate as initial treatment and maintenance therapy for hirsutism.
    Holdaway IM, Croxson MS, Ibbertson HK, Sheehan A, Knox B, France J.
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):522-9. PubMed ID: 2930987
    [Abstract] [Full Text] [Related]

  • 20. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human.
    Kumari GI, Das RP, Madoiya KK, Jain AK, Roy S.
    Fertil Steril; 1977 Nov; 28(11):1168-74. PubMed ID: 562781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.